Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1962 Aug 1;116(2):253–272. doi: 10.1084/jem.116.2.253

GLOMERULONEPHRITIS INDUCED IN SHEEP BY INJECTIONS OF HETEROLOGOUS GLOMERULAR BASEMENT MEMBRANE AND FREUND'S COMPLETE ADJUVANT

Raymond William Steblay 1
PMCID: PMC2137382  PMID: 13916466

Abstract

Sheep injected every 2 weeks with heterologous GBM and Freund's adjuvant by any one or combination of the following routes: intramuscular, subcutaneous, or intradermal, develop uniformly a fulminating, extracapillary glomerulonephritis, invariably fatal within 27 to 90 days after the first injection. The chief histologic feature is marked fibroepithelial proliferation of Bowman's capsule with crescent formation. The appearance of the lesions resembles the acute, subacute, and chronic stages of human glomerulonephritis, and depends on when the animal was sacrificed. Freund's adjuvant or heterologous GBM alone does not produce such a nephritis. The combination of placental tissue and Freund's adjuvant under the present experimental conditions was also unable to produce a nephritis. The clinical course, increase in nitrogen retention, evolution of renal lesions, and death, all describe a fulminating disease. The disease most characteristically resembles fatal, fulminating human subacute glomerulonephritis. The changes in serum proteins, decrease in serum albumin, and increase in serum globulin, occurred approximately the same in both the GBM-treated and the control adjuvant group. Similar changes have been reported from hyperimmunization alone, and so it is not clear how much these changes are due to immunization and how much is due to the nephritic process. The changes in serum cholesterol were not considered statistically significant. Circulating serum antibodies which localized (by fluorescent antibody technique in vitro) on basement membrane structures of the heterologous donor kidney antigen or which produced nephritis in the heterologous donor species (rat and dog) were found in serum of sheep sick or dying of nephritis. The passive transfer of nephritis by serum antibodies marks the first successful instance of transfer of nephritis by serum antibody to a heterologous species from an animal which had developed nephritis itself. The serum antibodies involved in the transfer of disease to the donor species appear to be unrelated to the mediators of nephritis in the sheep and may represent only the previously known heteronephrotoxic antibodies. By various biologic criteria the sheep nephritis presumably occurs by an autoimmune mechanism. However, it is not known whether the sheep nephritis is mediated by sensitized cells and/or antibodies. The latent period was estimated to end about 16 to 71 days after the first injection. Azotemia was estimated to begin about 17 to 78 days after the first injection. Proteinuria and azotemia began approximately 23 and 13 days before death. The rapid progression to a fatal termination defined the fulminating character of this disease.

Full Text

The Full Text of this article is available as a PDF (2.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAXTER J. H., GOODMAN H. C. Nephrotoxic serum nephritis in rats. I. Distribution and specificity of the antigen responsible for the production of nephrotoxic antibodies. J Exp Med. 1956 Oct 1;104(4):467–485. doi: 10.1084/jem.104.4.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BEVANS M., SEEGAL B. C. The production of glomerulonephritis by immunologic methods. J Chronic Dis. 1957 Jan;5(1):153–172. doi: 10.1016/0021-9681(57)90131-5. [DOI] [PubMed] [Google Scholar]
  3. Benacerraf B., Potter J. L., McCluskey R. T., Miller F. THE PATHOLOGIC EFFECTS OF INTRAVENOUSLY ADMINISTERED SOLUBLE ANTIGEN-ANTIBODY COMPLEXES : II. ACUTE GLOMERULONEPHRITIS IN RATS. J Exp Med. 1960 Jan 31;111(2):195–200. doi: 10.1084/jem.111.2.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. COONS A. H. Fluorescent antibody methods. Gen Cytochem Methods. 1958;1:399–422. [PubMed] [Google Scholar]
  5. DIXON F. J., FELDMAN J. D., VAZQUEZ J. J. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med. 1961 May 1;113:899–920. doi: 10.1084/jem.113.5.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. EARLE D. P., SEEGAL D. Natural history of glomerulonephritis. J Chronic Dis. 1957 Jan;5(1):3–13. doi: 10.1016/0021-9681(57)90120-0. [DOI] [PubMed] [Google Scholar]
  7. ELLIS H. A., WALTON K. W. Variations in serum complement in the nephrotic syndrome and other forms of renal disease. Immunology. 1958 Jul;1(3):234–250. [PMC free article] [PubMed] [Google Scholar]
  8. FISCHEL E. E., GAJDUSEK D. C. Serum complement in acute glomerulonephritis and other renal diseases. Am J Med. 1952 Feb;12(2):190–196. doi: 10.1016/0002-9343(52)90211-8. [DOI] [PubMed] [Google Scholar]
  9. FISCHEL E. E. Immune reactions in human glomerulonephritis. J Chronic Dis. 1957 Jan;5(1):34–44. doi: 10.1016/0021-9681(57)90123-6. [DOI] [PubMed] [Google Scholar]
  10. GERMUTH F. G., Jr, FLANAGAN C., MONTENEGRO M. R. The relationships between the chemical nature of the antigen, antigen dosage, rate of antibody synthesis and the occurrence of arteritis and glomerulonephritis in experimental hypersensitivity. Bull Johns Hopkins Hosp. 1957 Sep;101(3):149–169. [PubMed] [Google Scholar]
  11. HESS E. V., ASHWORTH C. T., ZIFF M. Transfer of an autoimmune nephrosis in the rat by means of lymph node cells. J Exp Med. 1962 Feb 1;115:421–438. doi: 10.1084/jem.115.2.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. HEYMANN W., HACKEL D. B., HARWOOD S., WILSON S. G., HUNTER J. L. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc Soc Exp Biol Med. 1959 Apr;100(4):660–664. doi: 10.3181/00379727-100-24736. [DOI] [PubMed] [Google Scholar]
  13. HEYMANN W., HUNTER J. L., HACKEL D. B. Experimental auto-immune nephrosis in rats: III. J Immunol. 1962 Feb;88:135–141. [PubMed] [Google Scholar]
  14. Hawn C. V., Janeway C. A. HISTOLOGICAL AND SEROLOGICAL SEQUENCES IN EXPERIMENTAL HYPERSENSITIVITY. J Exp Med. 1947 May 31;85(6):571–590. doi: 10.1084/jem.85.6.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. KRAKOWER C. A., GREENSPON S. A. Localization of the nephrotoxic antigen within the isolated renal glomerulus. AMA Arch Pathol. 1951 Jun;51(6):629–639. [PubMed] [Google Scholar]
  16. LIU C. T., McCRORY W. W. Autoantibodies in human glomerulonephritis and nephrotic syndrome. J Immunol. 1958 Dec;81(6):492–498. [PubMed] [Google Scholar]
  17. Lange K., Gold M. M., Weiner D., Simon V. AUTOANTIBODIES IN HUMAN GLOMERULONEPHRITIS. J Clin Invest. 1949 Jan;28(1):50–55. doi: 10.1172/JCI102052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. MELLORS R. C., ARIAS-STELLA J., SIEGEL M., PRESSMAN D. Analytical pathology. II. Histopathologic demonstration of glomerular-localizing antibodies in experimental glomerulonephritis. Am J Pathol. 1955 Jul-Aug;31(4):687–715. [PMC free article] [PubMed] [Google Scholar]
  19. MELLORS R. C., ORTEGA L. G. Analytical pathology. III. New observations on the pathogenesis of glomerulonephritis, lipid nephrosis, periarteritis nodosa, and secondary amyloidosis in man. Am J Pathol. 1956 May-Jun;32(3):455–499. [PMC free article] [PubMed] [Google Scholar]
  20. RIGGS J. L., SEIWALD R. J., BURCKHALTER J. H., DOWNS C. M., METCALF T. G. Isothiocyanate compounds as fluorescent labeling agents for immune serum. Am J Pathol. 1958 Nov-Dec;34(6):1081–1097. [PMC free article] [PubMed] [Google Scholar]
  21. STAVITSKY A. B., HACKEL D. B., HEYMANN W. Reduction of serum complement following in vivo tissue antigen-antibody reactions. Proc Soc Exp Biol Med. 1954 Apr;85(4):593–596. doi: 10.3181/00379727-85-20962. [DOI] [PubMed] [Google Scholar]
  22. STEBLAY R. W., LEPPER M. H. Some immunologic properties of human and dog glomerular basement membrane. I. Isolation of human glomerular basement membrane; similar or identical complement-fixing antigens in human and dog glomerular basement membrane preparations. J Immunol. 1961 Dec;87:627–635. [PubMed] [Google Scholar]
  23. STEBLAY R. W., LEPPER M. H. Some immunologic properties of human and dog glomerular basement membrane. II. Nephritis produced in dogs by rabbit antihuman glomerular basement membrane sera. J Immunol. 1961 Dec;87:636–646. [PubMed] [Google Scholar]
  24. STEBLAY R. W. Localization in human kidney of antibodies formed in sheep against human placenta. J Immunol. 1962 Apr;88:434–442. [PubMed] [Google Scholar]
  25. STEINER J. W., LANGER B., SCHATZ D. L. The local and systemic effects of Freund's adjuvant and its fractions. Arch Pathol. 1960 Oct;70:424–434. [PubMed] [Google Scholar]
  26. STETSON C. A., RAMMELKAMP C. H., Jr, KRAUSE R. M., KOHEN R. J., PERRY W. D. Epidemic acute nephritis: studies on etiology, natural history and prevention. Medicine (Baltimore) 1955 Dec;34(4):431–450. doi: 10.1097/00005792-195512000-00002. [DOI] [PubMed] [Google Scholar]
  27. WAKSMAN B. H. The distribution of experimental auto-allergic lesions. Its relation to the distribution of small veins. Am J Pathol. 1960 Dec;37:673–693. [PMC free article] [PubMed] [Google Scholar]
  28. WEIGLE W. O. The immune response of rabbits tolerant to bovine serum albumin to the injection of other heterologous serum albumins. J Exp Med. 1961 Jul 1;114:111–125. doi: 10.1084/jem.114.1.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wilson G. W., Oliver J. EXPERIMENTS ON THE PRODUCTION OF SPECIFIC ANTISERA FOR INFECTIONS OF UNKNOWN CAUSE : III. NEPHROTOXINS: THEIR SPECIFICITY AS DEMONSTRATED BY THE METHOD OF SELECTIVE ABSORPTION. J Exp Med. 1920 Jul 31;32(2):183–198. doi: 10.1084/jem.32.2.183. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES